PTHL (Pheton) Operating Profitability

Public company logo of Pheton Holdings Limited (PTHL)

Pheton Holdings Ltd maintains a hold on Chinese hospitals through specialized brachytherapy software, expanding via regional centers. Strong pricing power is driven by AI systems for precise radiation calculation. Revenues are based on the sale of oncology planning software. The operating profit margin demonstrates current efficiency, with the latest figure standing at -831.10, confirming the business's operational resilience.

Pheton Holdings Ltd (PTHL): Return on Sales by Operating Profit from 09/06/2024 to 01/16/2026

Pheton - analytical breakdowns and key metrics (PTHL)

- business market valuation indicators:
Fundamental company analysis:PTHL, Pheton Holdings
Finished products of Pheton Holdings Limited

Operating margin measures cost management efficiency, reflecting the share of profit from core operations before interest and taxes relative to total revenue. By analyzing the trend in operating profitability, an investor assesses the extent to which the monetization of innovations in precision brachytherapy at Pheton Holdings Ltd. (PTHL) transforms into actual operating income while minimizing costs associated with the implementation of high-tech cancer treatment systems.

Key competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.